Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nath Bio-Genes (India)'s Enterprise Value is ₹2,027 Mil.
Nath Bio-Genes (India)'s EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹623 Mil. Therefore, Nath Bio-Genes (India)'s EV-to-EBIT ratio for today is 3.25.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Nath Bio-Genes (India) (BOM:537291) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Nath Bio-Genes (India)'s current Enterprise Value is ₹2,027 Mil.
Nath Bio-Genes (India)'s EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹623 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Nath Bio-Genes (India)'s EV-to-EBITDA for today is:
Nath Bio-Genes (India)'s current Enterprise Value is ₹2,027 Mil.
Nath Bio-Genes (India)'s EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹663 Mil.
Nath Bio-Genes (India)'s current Enterprise Value is ₹2,027 Mil.
Nath Bio-Genes (India)'s Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,451 Mil.
Nath Bio-Genes (India)'s current Enterprise Value is ₹2,027 Mil.
Nath Bio-Genes (India)'s Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
Nath Bio-Genes (India)'s current Enterprise Value is ₹2,027 Mil.
Nath Bio-Genes (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nath Bio-Genes (India) Enterprise Value Related Terms
Nath Bio-Genes (India) Enterprise Value Historical Data
* Premium members only.
The historical data trend for Nath Bio-Genes (India)'s Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:537291 vs CTVA, CF, MOS: Enterprise Value Comparison
For the Agricultural Inputs subindustry, Nath Bio-Genes (India)'s Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nath Bio-Genes (India) Enterprise Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nath Bio-Genes (India)'s Enterprise Value distribution charts can be found below:
* The bar in red indicates where Nath Bio-Genes (India)'s Enterprise Value falls into.
Nath Bio-Genes (India) Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Nath Bio-Genes (India)'s Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nath Bio-Genes (India) (BOM:537291) has a Enterprise Value of ₹2,027 Mil as of Jul. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Nath Bio-Genes (India) and its competitors.
Is Nath Bio-Genes (India)'s Enterprise Value too high?
Nath Bio-Genes (India)'s current Enterprise Value is ₹2,027 Mil. Overall, Nath Bio-Genes (India) has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nath Bio-Genes (India)'s Enterprise Value compare to CTVA and CF?
Nath Bio-Genes (India)'s Enterprise Value of ₹2,027 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for an Agriculture company?
A good Enterprise Value depends on the Agriculture industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Nath Bio-Genes (India) and its competitors. Nath Bio-Genes (India)'s current Enterprise Value is ₹2,027 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nath Bio-Genes (India) stock overvalued right now?
Based on GuruFocus' analysis, Nath Bio-Genes (India) (BOM:537291) is currently considered Possible Value Trap. The stock's GF Value™ is ₹248.09, compared to a current price of ₹159.75 — trading 35.6% below its estimated fair value. The current Enterprise Value is ₹2,027 Mil. Nath Bio-Genes (India)'s overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Nath Bio-Genes (India) (BOM:537291), the current Enterprise Value is ₹2,027 Mil as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nath Bio-Genes (India) (BOM:537291) Overvalued in 2026?
Based on GuruFocus' analysis, Nath Bio-Genes (India) stock appears to be undervalued.
The current stock price of ₹159.75 is trading 35.6% below its estimated GF Value™ of ₹248.09.
GuruFocus considers Nath Bio-Genes (India) to be Possible Value Trap.
Key valuation signals for BOM:537291:
Enterprise Value: ₹2,027 Mil
GF Value™: ₹248.09 vs. price of ₹159.75 (35.6% below fair value)
No single metric tells the full story. See the BOM:537291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities; and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.
75GF Score
Get the complete analysis for BOM:537291
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:537291 has been successfully added to your 
